Yüklüyor......
Tildrakizumab: An Evidence-Based Review of Its Use in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
Psoriasis is a common immune-mediated chronic inflammatory disease, and observations have pointed toward the IL-23/Th17 cell axis as having a key role in the pathogenesis of psoriasis. This new immunological understanding of the pathogenesis has been translated into targeted and highly effective bio...
Kaydedildi:
| Yayımlandı: | Ther Clin Risk Manag |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7522402/ https://ncbi.nlm.nih.gov/pubmed/33061395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S227880 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|